These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 699245)
21. Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs. Freeman RH; Davis JO; Williams GM; DeForrest JM; Seymour AA; Rowe BP Circ Res; 1979 Oct; 45(4):540-5. PubMed ID: 225056 [TBL] [Abstract][Full Text] [Related]
22. The effect of the converting enzyme inhibitor SQ 20.881 on kinins, renin-angiotensin-aldosterone and catecholamines in relation to blood pressure in hypertensive patients. Hulthén L; Hökfelt B Acta Med Scand; 1978; 204(6):497-502. PubMed ID: 735881 [TBL] [Abstract][Full Text] [Related]
23. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency. McCaa RE Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226 [TBL] [Abstract][Full Text] [Related]
24. Interactions between coronary occlusion and the renin-angiotensin system in the dog. Ertl G; Alexander RW; Kloner RA Basic Res Cardiol; 1983; 78(5):518-33. PubMed ID: 6360140 [TBL] [Abstract][Full Text] [Related]
25. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810 [TBL] [Abstract][Full Text] [Related]
26. Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic-hormonal study. Ribner HS; Plucinski DA; Hsieh AM; Bresnahan D; Molteni A; Askenazi J; Lesch M Am J Cardiol; 1985 Nov; 56(13):896-904. PubMed ID: 3904388 [TBL] [Abstract][Full Text] [Related]
27. [Atrial natriuretic factor, catecholamines and the renin-angiotensin system in cardiac insufficiency. Relation to hemodynamic parameters]. Komajda M; Carayon A; Nguyen JP; Maistre G; Drobinski G; Legrand S; Landault C; Legrand JC; Grosgogeat Y Arch Mal Coeur Vaiss; 1988 Jul; 81(7):845-53. PubMed ID: 2973293 [TBL] [Abstract][Full Text] [Related]
28. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. Creager MA; Faxon DP; Cutler SS; Kohlmann O; Ryan TJ; Gavras H J Am Coll Cardiol; 1986 Apr; 7(4):758-65. PubMed ID: 3514728 [TBL] [Abstract][Full Text] [Related]
29. The effect of angiotensin converting enzyme inhibition of coronary blood flow and hemodynamics in patients without coronary artery disease. Faxon DP; Creager MA; Halperin JL; Sussman HA; Gavras H; Ryan TJ Int J Cardiol; 1982; 2(2):251-62. PubMed ID: 6185446 [TBL] [Abstract][Full Text] [Related]
30. Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade. Turini GA; Brunner HR; Ferguson RK; Rivier JL; Gavras H Br Heart J; 1978 Oct; 40(10):1134-42. PubMed ID: 708515 [TBL] [Abstract][Full Text] [Related]
31. Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics. Liang CS; Gavras H; Hood WB J Clin Invest; 1978 Apr; 61(4):874-83. PubMed ID: 659580 [TBL] [Abstract][Full Text] [Related]
32. Enalapril in congestive heart failure: acute hemodynamic and neurohumoral evaluation and short-term follow-up. Lin M; Chiang HT; Chang MS; Kong CW; Wang SP; Chiang BN Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jul; 48(1):31-40. PubMed ID: 1679372 [TBL] [Abstract][Full Text] [Related]
33. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review. Cody RJ Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842 [TBL] [Abstract][Full Text] [Related]
34. Splanchnic vasoconstriction in heat-stressed men: role of renin-angiotensin system. Escourrou P; Freund PR; Rowell LB; Johnson DG J Appl Physiol Respir Environ Exerc Physiol; 1982 Jun; 52(6):1438-43. PubMed ID: 7050057 [TBL] [Abstract][Full Text] [Related]
35. The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects. Sancho J; Re R; Burton J; Barger AC; Haber E Circulation; 1976 Mar; 53(3):400-5. PubMed ID: 174834 [TBL] [Abstract][Full Text] [Related]
36. Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit. Arnolda L; McGrath BP; Cocks M; Johnston CI J Clin Invest; 1986 Sep; 78(3):674-9. PubMed ID: 3528220 [TBL] [Abstract][Full Text] [Related]
37. Effects of a new angiotensin converting enzyme inhibitor, enalapril, in acute and chronic left ventricular failure in dogs. Leddy CL; Wilen M; Franciosa JA J Clin Pharmacol; 1983; 23(5-6):189-98. PubMed ID: 6308067 [TBL] [Abstract][Full Text] [Related]
38. Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure. Creager MA; Halperin JL; Bernard DB; Faxon DP; Melidossian CD; Gavras H; Ryan TJ Circulation; 1981 Sep; 64(3):483-9. PubMed ID: 6266691 [TBL] [Abstract][Full Text] [Related]
39. Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension. Crantz FR; Swartz SL; Hollenberg NK; Moore TJ; Dluhy RG; Williams GH Hypertension; 1980; 2(5):604-9. PubMed ID: 6158478 [TBL] [Abstract][Full Text] [Related]
40. Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension. Gavras H; Flessas A; Ryan TJ; Brunner HR; Faxon DP; Gavras I JAMA; 1977 Aug; 238(8):880-2. PubMed ID: 577978 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]